These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19348561)

  • 1. Baculovirus vector as a delivery vehicle for influenza vaccines.
    He F; Madhan S; Kwang J
    Expert Rev Vaccines; 2009 Apr; 8(4):455-67. PubMed ID: 19348561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient gene delivery into mammalian cells mediated by a recombinant baculovirus containing a whispovirus ie1 promoter, a novel shuttle promoter between insect cells and mammalian cells.
    Gao H; Wang Y; Li N; Peng WP; Sun Y; Tong GZ; Qiu HJ
    J Biotechnol; 2007 Aug; 131(2):138-43. PubMed ID: 17640755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens.
    Wu Q; Fang L; Wu X; Li B; Luo R; Yu Z; Jin M; Chen H; Xiao S
    Mol Immunol; 2009 Jul; 46(11-12):2210-7. PubMed ID: 19446339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
    Hüser A; Hofmann C
    Am J Pharmacogenomics; 2003; 3(1):53-63. PubMed ID: 12562216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development.
    Premanand B; Zhong Wee P; Prabakaran M
    Viruses; 2018 May; 10(6):. PubMed ID: 29857561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress on baculovirus-derived influenza vaccines.
    Cox MM
    Curr Opin Mol Ther; 2008 Feb; 10(1):56-61. PubMed ID: 18228182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baculovirus as an expression and/or delivery vehicle for vaccine antigens.
    Hu YC; Yao K; Wu TY
    Expert Rev Vaccines; 2008 Apr; 7(3):363-71. PubMed ID: 18393606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of influenza virus by baculovirus-mediated shRNA.
    Suzuki H; Saitoh H; Suzuki T; Takaku H
    Nucleic Acids Symp Ser (Oxf); 2009; (53):287-8. PubMed ID: 19749373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression.
    Shan L; Wang L; Yin J; Zhong P; Zhong J
    J Gene Med; 2006 Dec; 8(12):1400-6. PubMed ID: 17051599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FluBlok, a next generation influenza vaccine manufactured in insect cells.
    Cox MM; Hollister JR
    Biologicals; 2009 Jun; 37(3):182-9. PubMed ID: 19297194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baculovirus surface display of sigmaC and sigmaB proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model.
    Lin YH; Lee LH; Shih WL; Hu YC; Liu HJ
    Vaccine; 2008 Nov; 26(50):6361-7. PubMed ID: 18809448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel recombinant influenza vaccine in insect cells.
    McPherson CE
    Biologicals; 2008 Nov; 36(6):350-3. PubMed ID: 18804387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens.
    Lin SY; Chung YC; Hu YC
    Expert Rev Vaccines; 2014 Dec; 13(12):1501-21. PubMed ID: 25155825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring baculovirus-mediated efficiency of gene delivery.
    Mäkelä AR; Ernst W; Grabherr R; Oker-Blom C
    Cold Spring Harb Protoc; 2010 Mar; 2010(3):pdb.prot5397. PubMed ID: 20194466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
    Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baculovirus expression vector system for production of viral vaccines.
    Vlak JM; Keus RJ
    Adv Biotechnol Processes; 1990; 14():91-128. PubMed ID: 2222839
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor targeting of baculovirus displaying a lymphatic homing peptide.
    Mäkelä AR; Enbäck J; Laakkonen JP; Vihinen-Ranta M; Laakkonen P; Oker-Blom C
    J Gene Med; 2008 Sep; 10(9):1019-31. PubMed ID: 18655234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baculovirus surface display of NS3 nonstructural protein of classical swine fever virus.
    Xu XG; Tong DW; Chiou MT; Hsieh YC; Shih WL; Chang CD; Liao MH; Zhang YM; Liu HJ
    J Virol Methods; 2009 Aug; 159(2):259-64. PubMed ID: 19406162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).
    Doroshenko A; Halperin SA
    Expert Rev Vaccines; 2009 Jun; 8(6):679-88. PubMed ID: 19485748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baculovirus transduction of chondrocytes elicits interferon-alpha/beta and suppresses transgene expression.
    Lee HP; Matsuura Y; Chen HC; Chen YL; Chuang CK; Abe T; Hwang SM; Shiah HC; Hu YC
    J Gene Med; 2009 Apr; 11(4):302-12. PubMed ID: 19194979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.